| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/28/2001 | EP1087014A1 Hog cholera virus vaccine and diagnostic |
| 03/28/2001 | EP1087013A2 Immunoglobulins devoid of light chains |
| 03/28/2001 | EP1087011A2 Methods for preventing degradation of protein c |
| 03/28/2001 | EP1086956A1 Gene recombinant antibodies |
| 03/28/2001 | EP1086252A1 Herpes simplex virus origin binding protein n-terminal truncation (obp-nt) |
| 03/28/2001 | EP1086232A1 A vaccine-induced hepatitis b viral strain and uses thereof |
| 03/28/2001 | EP1086230A1 Bactericidal/permeability-increasing protein (bpi) deletion analogs |
| 03/28/2001 | EP1086225A2 Human tumour-derived polypeptide hormone phosphatonin |
| 03/28/2001 | EP1086223A2 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 03/28/2001 | EP1086222A2 Cell cycle regulation proteins |
| 03/28/2001 | EP1086217A2 Novel angiotensin receptor, production and use thereof |
| 03/28/2001 | EP1086205A1 Methods of monitoring disease states and therapies using gene expression profiles |
| 03/28/2001 | EP1086138A2 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 03/28/2001 | EP1086136A1 Monoclonal antibodies specific for guanidino group-derived advanced glycosylation endproducts in biological samples |
| 03/28/2001 | EP1086125A1 Respiratory nitrate reductase alpha subunit |
| 03/28/2001 | EP1086120A1 Method for preparing virus-safe pharmaceutical compositions |
| 03/28/2001 | EP1086119A1 Purification of antibodies |
| 03/28/2001 | EP1085903A1 Egg surface proteins and methods for use for modulating fertility |
| 03/28/2001 | EP1085897A1 Acrp30r1l, a homolog of acrp30 (30 kd adipocyte complement-related protein) |
| 03/28/2001 | EP1085882A2 Use of genetically engineered antibodies to cd38 to treat multiple myeloma |
| 03/28/2001 | EP0221173B1 Diagnostic reagents based on unique sequences within the variable region of the t cell receptor and uses thereof |
| 03/28/2001 | CN1288950A Preparation and application of monocloning antibody based on DNA immunity |
| 03/28/2001 | CN1288897A Preparation of human vasal endothelial cell growth inhibitor and its application in tumor angiogenesis resisting treatment |
| 03/28/2001 | CN1063796C Preparation method for drythropoietin isoforms |
| 03/28/2001 | CN1063795C Method for production of glucagon |
| 03/28/2001 | CN1063792C Hamanized antibodies and uses thereof |
| 03/28/2001 | CN1063757C Gene structure with calcitonin gene related peptide (CGRP) and preparing method thereof |
| 03/27/2001 | US6207815 Dna coding for chimeric heavy chain or antigen binding fragment produced by specific cell lines; combines with high molecular weight, tumor-associated sialylated glycoprotein antigen light chain; diagnosis; imaging |
| 03/27/2001 | US6207814 Activin receptor-like kinases, ALK-3 and ALK-6, and nucleic acids encoding them |
| 03/27/2001 | US6207812 Chondrosarcoma associated genes |
| 03/27/2001 | US6207811 Nephrin gene and protein |
| 03/27/2001 | US6207806 IGF-I purification process |
| 03/27/2001 | US6207805 Hybridoma which secretes monoclonal antibodies; diagnosis; anticarcinogenic agents with reduced side effects; imaging |
| 03/27/2001 | US6207804 Genetically engineered antibody analogues and fusion proteins thereof |
| 03/27/2001 | US6207803 Amino acid sequence of polypeptide; anticarcinogenic agents; antitumor agents; treatment of automimmune disorders, blood disorders; alzheimer's/parkinson's disease, septic shock, osteoporosis, polycystic kidney disease; viricides; diagnosis |
| 03/27/2001 | US6207802 Non-human, mammalian polypeptide of defined amino acid sequence which activates the growth of early hematopoietic progenitor cells; treatment of blood disorders; anticarcinogenic agents; bone marrow regeneration |
| 03/27/2001 | US6207801 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same |
| 03/27/2001 | US6207799 Neuropeptide Y receptor Y5 and nucleic acid sequences |
| 03/27/2001 | US6207647 Polynucleotides and polypeptides of the rat family, referred to as ?rata?; treatment of chlamydia infections |
| 03/27/2001 | US6207642 Member of the TNF family useful for treatment and diagnosis of disease |
| 03/27/2001 | US6207450 Nucleic acid of defined nucleotide sequence which encodes fkhl7 protein; drug screening; primers; probes; gene therapy; antibodies; recombinant production |
| 03/27/2001 | US6207449 Nucleotide sequence of gene; hybridization probes for detection; drug screening for bactericides, bacteriostats and antibiotics |
| 03/27/2001 | US6207418 Production of a multimeric protein by cell fusion method |
| 03/27/2001 | US6207417 DNA encoding stem cell factor |
| 03/27/2001 | US6207415 Preparing polypeptides in poultry embryonic tissues; propagating poultry tissues until tissue begins senescence, concentrating tissues, isolate non-senescent cells and propagate, recover polypeptides from tissues |
| 03/27/2001 | US6207413 Nucleotide sequence coding binding protein; for the diagnosis and treatment of endocrine defects |
| 03/27/2001 | US6207412 Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells |
| 03/27/2001 | US6207411 Bacteriocins |
| 03/27/2001 | US6207401 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders |
| 03/27/2001 | US6207386 Compositions for the treatment and diagnosis of body weight disorders, including obesity |
| 03/27/2001 | US6207383 Adjusted nucleotide sequences associated with genetic disorder; for the diagnosis, treatment and prevention of arrhythmia |
| 03/27/2001 | US6207378 Method for amplifying nucleic acid molecules and method for synthesizing proteins |
| 03/27/2001 | US6207374 Tuberous sclerosis 2 gene and uses thereof |
| 03/27/2001 | US6207169 Compounds and methods for the diagnosis and treatment of Ehrlichia infection |
| 03/27/2001 | US6207162 AspS from Chlamydia trachomatis |
| 03/27/2001 | US6207158 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof |
| 03/27/2001 | US6207153 Antigen binding polypeptide |
| 03/27/2001 | US6207152 Anticancer agent |
| 03/27/2001 | US6207146 Gene expression in mammalian cells |
| 03/27/2001 | CA2201098C Orphan receptor |
| 03/27/2001 | CA2135200C Canine coronavirus s gene and uses therefor |
| 03/27/2001 | CA2123107C Ubiquitin-specific proteases |
| 03/27/2001 | CA2076540C Recombinant antibodies specific for tnf-.alpha. |
| 03/27/2001 | CA2008304C Assay for bone alkaline phosphatase |
| 03/27/2001 | CA1341211C Mini-proinsulin, its preparation and use |
| 03/27/2001 | CA1341208C Proteins with factor viii activity, process for their preparation using genetically engineered cells and pharmaceutical compositions containing them |
| 03/23/2001 | CA2309372A1 Use of antibodies against the nef protein for decreasing the chemotaxis which is induced by retrovirus-infected astrocytes |
| 03/22/2001 | WO2001020038A1 Novel cell cycle checkpoint genes and proteins encoded thereby |
| 03/22/2001 | WO2001020031A2 Polymorphisms in a klotho gene |
| 03/22/2001 | WO2001020026A2 POLYMORPHISMS IN THE HUMAN hPXR GENE AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 03/22/2001 | WO2001020025A2 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 03/22/2001 | WO2001020016A2 Method for increasing the yield of recombinant proteins in microbial fermentation processes |
| 03/22/2001 | WO2001020005A1 Regulatory sequences and expression cassettes for yeasts, especially for kluyveromyces |
| 03/22/2001 | WO2001019992A2 FACTOR IX/FACTOR IXa ANTIBODIES AND ANTIBODY DERIVATIV ES |
| 03/22/2001 | WO2001019983A1 Human g-protein coupled receptor |
| 03/22/2001 | WO2001019861A2 Apo-2 receptor antibodies |
| 03/22/2001 | WO2001019860A2 Proteins associated with cell differentiation |
| 03/22/2001 | WO2001019856A2 Secreted human proteins, polynucleotides encoding them and methods of using the same |
| 03/22/2001 | WO2001019846A1 Transgenically produced fusion proteins |
| 03/22/2001 | WO2001019393A1 Delivering to eucaryotic cells bacterial proteins that are secreted via type iii secretion systems |
| 03/22/2001 | WO2001019335A2 Composition to be administered through mucous membrane |
| 03/22/2001 | WO2001009332A3 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof |
| 03/22/2001 | WO2000063240A9 ANTIFUNGAL AGENTS ISOLATED FROM $i(PSEUDOMONAS SYRINGAE) |
| 03/22/2001 | WO2000059943A3 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE |
| 03/22/2001 | WO2000020591A9 Tgf-beta superfamily mutant members, including morphogenic proteins |
| 03/22/2001 | WO2000018421A9 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 03/22/2001 | WO1999058678A9 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 03/22/2001 | DE19943919A1 Verfahren zur Steigerung der Ausbeute von rekombinanten Proteinen in mikrobiellen Fermentationsprozessen A method for increasing the yield of recombinant proteins in microbial fermentation processes |
| 03/22/2001 | CA2384876A1 Composition to be administered through mucous membrane |
| 03/22/2001 | CA2384762A1 Apo-2 receptor antibodies |
| 03/22/2001 | CA2384749A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 03/22/2001 | CA2384660A1 Factor ix/factor ixa antibodies and antibody derivatives |
| 03/22/2001 | CA2384324A1 Proteins associated with cell differentiation |
| 03/22/2001 | CA2383831A1 Method for increasing the yield of recombinant proteins in microbial fermentation processes |
| 03/22/2001 | CA2383177A1 Human g-protein coupled receptor |
| 03/22/2001 | CA2382725A1 Transgenically produced fusion proteins |
| 03/22/2001 | CA2381347A1 Regulatory sequences and expression cassettes for yeasts |
| 03/22/2001 | CA2381066A1 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications |
| 03/22/2001 | CA2379541A1 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 03/21/2001 | EP1085088A1 Monoclonal antibodies and method for assaying fdp |